Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Recruiting × molgramostim × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1

Interventions

Cyclophosphamide 14 fludarabine 11 Magnetic Resonance Spectroscopy 11 pembrolizumab 8 Specimen Handling 6 Paclitaxel 5 Immunotherapy, Adoptive 5 Fluorodeoxyglucose F18 5 Radiotherapy 4 Immune Checkpoint Inhibitors 4 Cisplatin 4 Carboplatin 4 ruxolitinib 3 lenvatinib 3 fluciclovine F-18 3 X-Rays 3 Surgical Procedures, Operative 3 Etoposide 3 Doxorubicin 3 Dexamethasone 3 Dasatinib 3 Cholecalciferol 3 68Ga-FAPI 3 venetoclax 2 tislelizumab 2 temsirolimus 2 olaparib 2 daratumumab 2 aldesleukin 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07341360 2026-01-14

Pseudovax

Oslo University Hospital

Phase EARLY_PHASE1 Recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡